Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J WHANG

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 30, 2000
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapyY Chen, R P Perng, K Y Yang, et al.
Cancer Genetics and Cytogenetics|January 1, 1986
Methodologic advances in the cytogenetic analysis of human solid tumorsJ Trent, K Crickard, Z Gibas, et al.
International Journal of Cancer|May 2, 1997
Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinomaY J Chen, J G Chang, L S Shih, et al.
International Journal of Cancer|August 22, 1997
Microsatellite instability in sporadic-colon-cancer patients with and without liver metastasesW S Chen, J Y Chen, J M Liu, et al.
Journal of Medical Ethics|August 26, 1999
The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centreJ M Liu, W C Lin, Y M Chen, et al.
Cancer Genetics and Cytogenetics|June 1, 1982
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC)J Whang-Peng, P A Bunn, C S Kao-Shan, et al.
Journal of the National Cancer Institute|March 1, 1980
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristicsI T Magrath, P A Pizzo, J Whang-Peng, et al.
Genes, Chromosomes & Cancer|May 1, 1991
Nonrandom structural and numerical chromosome changes in non-small-cell lung cancerJ Whang-Peng, T Knutsen, A Gazdar, et al.
British Journal of Cancer|January 22, 2004
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreatedY-M Chen, R-P Perng, J-F Shih, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 1, 1996
Lack of NK cells and related cytokines in pleural effusionY M Chen, J Whang-Peng, W K Yang, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Lung Cancer (Amsterdam, Netherlands)|August 30, 2000
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapyY Chen, R P Perng, K Y Yang, et al.
Cancer Genetics and Cytogenetics|January 1, 1986
Methodologic advances in the cytogenetic analysis of human solid tumorsJ Trent, K Crickard, Z Gibas, et al.
International Journal of Cancer|May 2, 1997
Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinomaY J Chen, J G Chang, L S Shih, et al.
International Journal of Cancer|August 22, 1997
Microsatellite instability in sporadic-colon-cancer patients with and without liver metastasesW S Chen, J Y Chen, J M Liu, et al.
Journal of Medical Ethics|August 26, 1999
The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centreJ M Liu, W C Lin, Y M Chen, et al.
Cancer Genetics and Cytogenetics|June 1, 1982
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC)J Whang-Peng, P A Bunn, C S Kao-Shan, et al.
Journal of the National Cancer Institute|March 1, 1980
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristicsI T Magrath, P A Pizzo, J Whang-Peng, et al.
Genes, Chromosomes & Cancer|May 1, 1991
Nonrandom structural and numerical chromosome changes in non-small-cell lung cancerJ Whang-Peng, T Knutsen, A Gazdar, et al.
British Journal of Cancer|January 22, 2004
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreatedY-M Chen, R-P Perng, J-F Shih, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 1, 1996
Lack of NK cells and related cytokines in pleural effusionY M Chen, J Whang-Peng, W K Yang, et al.
Pageof 22